Showing 17,081 - 17,100 results of 44,223 for search '(( 50 ((026 decrease) OR (a decrease)) ) OR ( 5 ((nn decrease) OR (mean decrease)) ))', query time: 0.96s Refine Results
  1. 17081
  2. 17082

    PEA performed for different durations of incubation after the dilution step, for three concentrations of rPCT. by Frederic Bedin (3402254)

    Published 2023
    “…<p>The incubation time after dilution of the binding product was progressively decreased from 5 min (reference test, ref.) down to 30 sec. …”
  3. 17083

    PEA performed for different durations of antigen/antibody binding, for three concentrations of rPCT. by Frederic Bedin (3402254)

    Published 2023
    “…<p>The time of incubation between the rPCT and the PEA probes was progressively decreased from 1h (reference test, ref.) down to 5 minutes. …”
  4. 17084
  5. 17085

    Serum lipoxin A4 (LXA4) and resolvin D1 (RvD1) deficiency in patients with sleep-disordered breathing. by Yung-Che Chen (381913)

    Published 2019
    “…<p>(A) Serum RvD1 and (B) LXA4 levels were both decreased in patients with primary snoring (PS), treatment-naïve OSA, and severe OSA on CPAP treatment as compared with that in the healthy subjects (HS). …”
  6. 17086

    Mapping the properties of cells in relation to their local neighborhood. by Matthew French (13007466)

    Published 2025
    “…<b>D:</b> Heightened TBXT and TBX6 CV to the NMP region and decreases into the mesodermal PS. Lines indicate the fit of a non-parametric multiple regression curve and shading indicates 0.05 and 0.95 confidence intervals calculated as (mean ± 1.96 * (<i>σ</i>/(√<i>n</i>)). …”
  7. 17087
  8. 17088
  9. 17089

    Population impact of lung cancer screening in the United States: Projections from a microsimulation model by Steven D. Criss (3821332)

    Published 2018
    “…</p><p>Methods/Findings</p><p>Utilizing a well-validated microsimulation model, we estimated the benefits and harms of an annual low-dose computed tomography screening scenario with a realistic screening adherence rate versus a no-screening scenario for the US population from 2016–2030. …”
  10. 17090

    FPR1/2/3 expressions of human monocytic THP-1 cells exposed to normoxia (NOX), 2 days of persistent hypoxia (PH), or 2 days of intermittent hypoxia with re-oxygenation (IHR). by Yung-Che Chen (381913)

    Published 2019
    “…<p>The box plots show the 25th, 50th, 75th percentiles, maximum, and minimum. IHR treatment resulted in increased (A) FPR1 and (B) FPR2 expressions on M2a cells. …”
  11. 17091
  12. 17092

    The effect of cPTIO pre-treatment on cell death rate. by Bushra Ijaz (4353385)

    Published 2019
    “…<p>Cell death rate as measured in tolerant (a) and sensitive (b) cell cultures after 50uM cPTIO pre-treatment and 100 and 150mM NaCl stress. …”
  13. 17093
  14. 17094
  15. 17095

    Agonistic activity of tamoxifen, a selective estrogen-receptor modulator (SERM), on arthritic ovariectomized mice by L.A.S. Silva (4617988)

    Published 2017
    “…<div><p>Arthritis is positively associated with the decline of sex hormones, especially estrogen. Tamoxifen (TMX) is a selective estrogen receptor modulator, possessing agonist or antagonistic activity in different tissues. …”
  16. 17096
  17. 17097
  18. 17098
  19. 17099

    Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial by Martin Koppitz (2838347)

    Published 2016
    “…Interestingly, there was a mean increase in all inflammatory cytokines (IL-1β, IL-6, and IL-8) during the saline treatment from day 1 to week 3, whereas during the Tyloxapol treatment, all cytokines decreased. …”
  20. 17100